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Abstract
Background: In the field of health technology assessment (HTA), there are several approaches that can be used for
ethical analysis. However, there is a scarcity of literature that critically evaluates and compares the strength and
weaknesses of these approaches when they are applied in practice. In this paper, we analyse the applicability of
some selected approaches for addressing ethical issues in HTA in the field of complex health interventions. Complex
health interventions have been the focus of methodological attention in HTA. However, the potential methodological
challenges for ethical analysis are as yet unknown.
Methods: Six of the most frequently described and applied ethical approaches in HTA were critically assessed
against a set of five characteristics of complex health interventions: multiple and changing perspectives, indeterminate
phenomena, uncertain causality, unpredictable outcomes, and ethical complexity. The assessments are based on
literature and the authors’ experiences of developing, applying and assessing the approaches.
Results: The Interactive, participatory HTA approach is by its nature and flexibility, applicable across most complexity
characteristics. Wide Reflective Equilibrium is also flexible and its openness to different perspectives makes it better
suited for complex health interventions than more rigid conventional approaches, such as Principlism and Casuistry.
Approaches developed for HTA purposes are fairly applicable for complex health interventions, which one could
expect because they include various ethical perspectives, such as the HTA Core Model® and the Socratic approach.
Conclusion: This study shows how the applicability for addressing ethical issues in HTA of complex health
interventions differs between the selected ethical approaches. Knowledge about these differences may be helpful
when choosing and applying an approach for ethical analyses in HTA. We believe that the study contributes to
increasing awareness and interest of the ethical aspects of complex health interventions in general.
Keywords: Health technology assessment, bioethics, complex health intervention
Background
Ethics has been on the health technology assessment
(HTA) agenda since the inception of HTA. This is
reflected in the definition of HTA: “a multidisciplinary
process that summarises information about the medical,
social, economic and ethical issues related to the use of
a health technology in a systematic, transparent, un-
biased, robust manner. Its aim is to inform the formula-
tion of safe, effective, health policies that are patient
focused and seek to achieve best value” [1]. Ethics
should be integrated in HTA for a number of reasons. In
HTA, the merits of health technologies are evaluated for
the purpose of informing decision making in health care.
This is a normative issue because health technologies
and health care have a moral intention to help people,
by improving health status, relieving pain etc., i.e. pro-
moting a good life [2]. The core issues in HTA, such as
safety and effectiveness, also raises moral questions
about how these issues should be defined and measured,
e.g. the limits for safety [2]. Moreover, including ethics
can make HTA more efficient and the subsequent deci-
sions more informed and accountable, thereby avoiding
the HTA results being in conflict with social and moral* Correspondence: kristin.bakke-lysdahl@hioa.no
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values [2]. Cochlear Implants (CI) for children is a well
know example where there are conflicting values [3],
which demonstrate the importance of including ethics in
HTA. A reason for the controversy was that CI can be
seen as a remedy of a medical condition (deafness) or a
threat against the Sign Language as a natural language
in the Deaf community.
Over the years, a series of methods for ethical analysis
in HTA have been developed and suggested [4]. How-
ever, there has not been a general acceptance for incorp-
orating ethics in the HTA process until recently [5, 6],
and ethics is still “rarely addressed explicitly in HTA re-
ports” [7]. A survey of HTA reports published in the
period 2003 to 2006 by HTA agencies in Canada, UK,
Denmark and USA, showed that ethical, social and
organizational issues, in addition to clinical and eco-
nomic evaluations, were only considered in 5 % of the
(223) reports found [4]. One of the many possible rea-
sons for this [8] may be that the methods generally need
further development to be feasible to the users. Accord-
ing to Assasi et al. [4], we lack studies that critically
evaluate the characteristics of the available ethical ap-
proaches. Another reason may be that, as health inter-
ventions become more complex, existing methods for
addressing ethical issues in HTA are not suitable for
such interventions.
Recently the methodological challenges associated
with complex health interventions1 for systematic re-
views and evidence synthesis in HTA have gained much
interest [9]. Complexity is associated with uncertainty
and unpredictability, and most health interventions are
complex to some degree. Highly complex health inter-
ventions, such as lifestyle interventions and treatment
for chronic diseases, pose particular challenges for HTA,
e.g. in terms of heterogeneous study designs. However,
little interest has been shown about how complex health
interventions may cause possible methodological chal-
lenges for ethical analysis in HTA. The aim of this paper
is to investigate how applicable existing ethical ap-
proaches are for addressing ethical issues in HTA of
complex health interventions. The applicability assess-
ment will indicate how the approaches can be amended
or improved to better address ethical aspects of com-
plex2 health interventions.
Methods
(Bio)medical ethics is a multidisciplinary field, i.e. a field
that involves a range of disciplines3 that investigate the
subject matter of medicine, health care and the life sci-
ences using a wide variety of methods [10]. Accordingly,
a series of methods or approaches are relevant for eth-
ical assessment in HTA. These are fairly well mapped
out, e.g. identified in the HTA Core Model®,4 in surveys
[6, 11] and a recent systematic review [4]. Additionally,
the authors of this study have made several contribu-
tions to the field, are active participants in e.g.
EUnetHTA, HTAi-INAHTA Special Interest Group on
Ethical issues in HTA and have followed the field for
several years. Not all approaches used to address ethical
issues in HTA can be assessed and presented in this
study. Therefore, only approaches that are frequently de-
scribed and used in HTA reports and peer reviewed arti-
cles and approaches initially considered to have the
potential for addressing ethical issues in complex inter-
ventions are included.5 Three general approaches in eth-
ics used in HTA are considered: The four principles
approach, Casuistry, and Wide Reflective Equilibrium
(coherence analysis). Additionally, three HTA specific
approaches are selected: Interactive, participatory HTA
approaches (iHTA), the HTA Core Model®, and the So-
cratic approach.
To assess the included approaches, we used an estab-
lished set of characteristics of complexity that have eth-
ical relevance: 1) multiple and changing perspectives, 2)
indeterminate phenomena, 3) uncertain causality, 4) un-
predictable outcomes, and 5) ethical complexity.6 These
five characteristics are explained in Table 1, where some
implications for ethical analyses in HTA are also given.
The development of the set of ethically relevant com-
plexity characteristics is mainly based on a) publications
by the UK Medical Research Council [12], b) a recent
paper by Petticrew and colleagues [9], and c) our delib-
erations about additional ethics specific characteristics,
which is described elsewhere.7
Unfortunately, the literature reporting on ethics ana-
lysis of complex interventions is too small for a system-
atic review and an analysis of how suitable the various
ethics approaches are for such interventions. Therefore,
we were forced to analyse and discuss the various ethical
approaches against a set of complexity characteristics.8
Results and discussion
In the following text, we briefly present the selected ap-
proaches for addressing ethical issues in HTA before
analysing and discussing their appropriateness for com-
plex health interventions, according to the characteris-
tics presented in Table 1. Table 2 gives an overview of
the results of these analyses.
The four principle approach
The most frequently used form of Principlism (i.e. to
apply principles to solve moral problems) addresses the
four basic ethical principles: respect for autonomy, non-
maleficence, beneficence and justice [13]. These princi-
ples have a prima facie nature, which means that the
principle must be fulfilled unless it conflicts with an
equal or stronger obligation. The principles constitute a
basic framework and they need to be specified and
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balanced (i.e. the practical activity becomes that of spe-
cifying how the principles are to be used in specific situ-
ations and balancing the principles with the other
competing moral principles). Principlism is a popular
approach because it is simple and feasible. Its simplicity
lies in the application of a stable set of ethical themes
and concepts [14]. However, this simplicity also consti-
tutes the major limitation of the approach: the risk of
leaving out a series of values and perspectives. Further-
more, it has been questioned whether the (in this case
four) principles (and only these) are universal [15].
Principlism and the characteristics of complexity
Variety of perspectives Principlism is not designed as a
participatory approach. It primarily takes into account
physicians’ and patients’ perspectives, but tends to leave
other stakeholder perspectives out. Society's perspective
is taken into account (principle of justice), although in a
top-down manner, i.e. according to the perspective of
the user of the approach. Therefore, Principlism is only
partially suited to address multiple perspectives and
goals.
The four principles entail taking account of the view of
physicians, patients and society. Therefore, the approach
may encourage the user to think about normative issues
and the implications of interactions/relationship between
agents (particularly physician-patient relationships). Issues
of control, decision-making and related responsibilities
are not addressed in this approach.
Indeterminate phenomena Respecting the principles of
beneficence/non-maleficence requires a strict evaluation
of the benefits and risks related to the use of technolo-
gies. However, the indeterminacy of the intervention
and/or the target condition would make this type of
evaluation difficult or even impossible. This means that
Principlism is not very useful for identifying moral
challenges related to indeterminate phenomena. This
has been acknowledged e.g. in the case of nanotechnol-
ogies where the toxicological risk assessment for use of
nanomaterials is difficult. Therefore, establishing the
right balance between benefits for patients and society
and risks of harms may be unclear [16].
Uncertain causality As mentioned above, Principlism is
not suitable for handling uncertainty. The symbolic
value of an intervention is not addressed and the impact
of context on outcome may be only partially recognized
(subject to pure speculation).
Principlism does not directly include questions about
morally relevant methodological choices in the HTA.
Nevertheless, this approach requires data to be available on
safety, efficacy/effectiveness (principles of non-maleficence/
beneficence) and economic impact (principle of justice)
related to the interventions. In this sense, Principlism may
influence some choices in the HTA process.
Unpredictable outcomes Principlism may encourage
the user to think about some possible outcomes or
Table 1 Characteristics of complexity, short explanations and implications for ethics analysis
Characteristic Short explanation Implications for ethical analysis in HTAa
Multiple and changing
perspectives
The variety of perspectives is caused by the many
components (social, material, theoretical, and procedural
[51]), actors, stakeholders, organisational levels involved.
Additionally, these are interconnected and interacting.
Address the variety of perspectives (typically the stakeholders’
interests and intentions), questions about normative
implications of interconnectedness and interactions between
actors/components, and moral questions related to control
and decision making.
Indeterminate phenomena The interventions or health condition cannot be strictly
defined or delimited due to characteristics like flexibility,
tailoring, self-organization, adaptivity, and evolution over time.
Identify moral challenges related to indeterminacy of the
intervention and/or the target medical condition(s). E.g.
identify possible contradictory interpretationsb and alternative
use of the intervention, and the justifications of these.
Uncertain causality Factors like synergy between components, feedback loops,
moderators and mediators of effect, context and the
symbolic value of the intervention lead to uncertain causal
pathways between intervention and outcome.
Address morally relevant issues related to methodological
choices in the HTA itself. The uncertainties call for transparency
and openness about the grounds for the choices and an
integrative approach.
Unpredictable outcomes The outcomes of the intervention may be many, variable,
new, emerging and unexpected.
Address ethical challenges of handling outcome uncertainties,
regarding outcome type, size, for whom/at what level, and at
what time.
Ethical complexity Interventions are especially ethically complex because of
contradictions between basic ethical principles, or because
fundamental moral or sociocultural values are at stake.
Reveal underlying norms and values, and elucidate possible
contradicting principles or values (resolvability).Reveal
potential fundamental ethical, social, cultural values at stake,
and contribute to handling of conflicting concerns. Clarity
of aim and scope of ethical analyses (conclusiveness and
integration in HTA), and comprehensiveness and
transparency of reporting are essential.
aDescribing some obvious implications certainly does not exclude the possibility of other relevant implications
bThe indeterminacy of complex interventions allows for interpretations in different, also contradictory, ways, (i.e. paradoxes need careful scrutiny and conciliation
of interpretations to be resolved) [52]
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Table 2 Summarized assessment of the ethical approaches according to characteristics of complexity
Aspects of complexity
Ethical approach Plurality of perspectives Indeterminate phenomena Uncertain causality Unpredictable outcomes Ethical complexity
Principlism Hardly applicable: A limited
number of perspectives are
included, the implications of
interactions between agents are
partially included.
Hardly applicable: Questions
related to indeterminacy are not
addressed.
Hardly applicable: Data required
by the approach indicates that
methodological choices in the
HTA process may be partially
addressed.
Hardly applicable: Ethical issues
of outcomes are addressed, but
not the uncertainties in
outcomes as such.
Fairly applicable: Conflicting of
principles can be illuminated,
but not always overcome
(resolvability).
Casuistry Hardly applicable: Analogues can
provide solutions taking
different perspectives into
account, but may not be
suitable for joining/synthesizing/
com-promising perspectives, or
to address interconnectedness/
interactions.
Hardly applicable: Analogues can
provide potential conceptions of
indefinite phenomena, but there
is a threat of over-simplification.
Hardly applicable: Analogues
may address uncertainties.
However, whether the
analogues will handle relevant
potential uncertainties cannot
be predicted.
Hardly applicable: Analogues
may address un-predictability,
but it may also mask basic or
dynamic challenges, such as
unpredictable outcomes.
Fairly applicable: Casuistry is
excellent for finding solutions
to morally challenging
problems. However, Casuistry
does not provide solutions to
genuine paradoxes and aporias.
It may be useful to highlight
them, though.
Wide Reflective Equilibrium,
(coherence analysis)
Fairly applicable: WRE can take
into account of multiple
perspectives and differences in
judgement of moral properties.
Interaction between
components may be addressed
in the WRE process. Control and
decision-making is issued by the
aim of providing a coherent
base for this.
Applicable: The moral
implications of the indeterminacy
of the intervention or condition
can be revealed and explored in
discussions towards equilibrium.
Fairly applicable: Do not address
moral issues related to
methodological choices in HTA
in general, but recognises the
uncertainties from context
dependency and the importance
of taking this in to account.
Fairly applicable: Can
accommodate different views of
what constitute relevant end
points. Unexpected outcomes
may be interpreted as
disruption of the equilibrium,
calling for a renewed debate.
Fairly applicable: WRE can reveal
fundamental values at stake,
take value conflicts into account,
elucidate contractions and
inform about their resolvability.
The aim of WRE is clear, but
quality of reporting is not
explicitly addressed.
Interactive, participatory
HTA approaches (iHTA)
Applicable: iHTA is pre-eminently
suited to take into account a
variety of perspectives, and
interaction between actors.
Applicable: Indeterminacy of a
technology and its use is
acknowledged.
Applicable: Stakeholder
involvement in the assessment
process facilitates addressing
ethical challenges in
methodological choices.
Fairly applicable: The approach is
likely to increase the range of
outcomes taken into account,
which indicates that the ethical
challenges of this unpredictability
are also addressed.
Fairly applicable: Stakeholders
may reveal fundamental moral
or socio-cultural values
involved, and may elucidate
the resolvability of possible
contradicting principles/
values.
The HTA Core Model® Fairly applicable: Different
perspectives are included
through stakeholder
involvement and cooperation
with experts in other HTA-areas.
Interactions/interrelations are
not specified or related to
ethical implications.
Hardly applicable: Defining the
technology and target group is
addressed in another domain of
the model. Ethical implications
of indeterminacy of technology/
condition, are not addressed,
but an illustration of ethical
relevance of defining the target
group is given.
Fairly applicable: Morally relevant
issues related to
methodological choices are
addressed in the introduction to
the core model, and to some
extent in the ethics domain.
Factors contributing to
uncertain causality are not
specifically included, but
context is indirectly considered
though context dependent
values.
Applicable: Outcome
uncertainties are addressed in
the “beneficence/non-
maleficence” issue, and in some
other parts of the model.
Fairly applicable: Some
fundamental values are directly
addressed, others may be
revealed by stakeholder
involvement, which also may
reveal contradicting principles/
values. The contribution to
handling conflicting concerns is
limited. The (common)
reporting structure contributes
to transparency.
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Table 2 Summarized assessment of the ethical approaches according to characteristics of complexity (Continued)
The Socratic approach Fairly applicable: Identifies actors
and stakeholders, and their
perspectives, interest etc.
Normative implications of
interactions between agents
(and components in general) are
partly covered. Decision-making
and responsibilities are also
touched upon.
Fairly applicable: Provides a
means for exploring various
definitions/under-standing of
the interventions. The moral
impact of indeterminacy is not
directly addressed, but may be
illuminated through related
questions.
Applicable: Morally relevant
methodological choices in HTA
are well addressed, which can
contribute to an improvement
in taking causal pathway
uncertainties into account.
Fairly applicable: Variety in
outcomes is not specifically
addressed, but rather a series of
moral question about different
potential outcomes.
Fairly applicable: Reveals
fundamental values and
contribute to elucidate
contradictions. The clear
descriptive aim limits the
contribution to handling
conflicting concerns and
contradictions.
Comprehensiveness and
transparency in reporting is
emphasised.
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consequences of an intervention, particularly benefits and
harms (beneficence/non-maleficence), change of patient
role (respect for autonomy) and effects on the distribution
of health care resources (principle of justice). These issues
are always addressed in a top-down manner, therefore
they may be subject to pure speculation. Principlism is not
suitable for handling uncertainties in outcomes (whatever
the cause, type and size), e.g. if some kind of uncertainty
itself may infer harm or challenge autonomy.
Ethical complexity Principlism may be excellent for
identifying possible contradictions (e.g. the conflict be-
tween autonomy and beneficence for single persons on
the one hand, and the just distribution of resources and
beneficence for society on the other). In addition, the
“balancing activity” of Principlism may be a useful “tool”
for solving possible conflicts and elucidating which
moral norms should prevail. Even if identifying and bal-
ancing contradictions is apparently simple and feasible,
it may not provide incontrovertible solutions to possible
conflicts in practice, since there is no unified moral the-
ory from which the four principles are derived. Besides,
some contradictions may be overlooked due to the lim-
ited scope of the four principles approach.
In summary, Principlism does not seem well suited for
addressing several aspects of complexity (see Table 2).
Hence, where this is applied to complex interventions
the approach needs supplementing and stakeholder con-
sultation may be especially helpful in these cases.
Casuistry
With deep roots in ancient moral philosophy and mod-
ern anti-theoretical bioethics [17], Casuistry uses prac-
tical cases with an undisputed solution to solve the
moral challenging situation or dilemma in hand. Ori-
ented away from theory or principles and towards the
particular, the procedure in Casuistry starts by identify-
ing the structure of the case, i.e., by describing the cir-
cumstances (who, what, when, where, how, by what
means) and the relevant maxims involved, e.g., “the
morals of the story.” Then it compares the case with
similar “paradigmatic” cases [10]. Paradigmatic cases are
those where a solution is found which is generally ac-
cepted. The comparison of cases should reveal the moral
maxims at stake and the subsequent practical implica-
tions [18]. In HTA, Casuistry can be at play informally,
e.g. when referring to solved cases such as coverage de-
cisions, but it can also be more formally applied [19]. As
with other approaches in applied ethics, Casuistry has its
shortcomings, e.g. potential changes in the value base
between past precedents and current cases [18], and it
“suffers from the potential limitations of relying on sub-
jective analogic arguments and intuitive judgment about
a particular case” [4].
Casuistry and the characteristics of complexity
Variety of perspectives Casuistry is well suited to ad-
dressing multiple perspectives and goals, as earlier cases
may have found (combined or compromised) solutions.
The rejection of universal moral norms also fits the need
for flexibility in complex interventions. This makes it
possible to take into account how socio-cultural, reli-
gious etc. circumstances matter in the comparing case,
and analyse the similarities with the case under investi-
gation. Moreover, different types of experts may take
part in the explication of an ethical problem in Casuis-
try, which may enable the capturing of possible ethical
issues arising from a ‘number of groups or
organizational levels targeted by the intervention.’ How-
ever, to find cases that join, synthesize, or compromise
various perspectives may be challenging. The chosen an-
alogues (paradigmatic cases) instead tend to favour one
perspective. E.g., it is difficult to find an analogue to sub-
stance abuse that both embraces “victim-of-disease” and
“weakness-of-the-will” perspectives. The same challenge
occurs when trying to address interconnectedness and
interactions between relevant components of health
interventions.
Indeterminate phenomena Analogies may be used to
conceptualize vague or indefinite phenomena [20, 21].
However, it may be difficult to find analogies that bear
sufficient breadth and similarity to the intervention one
is assessing. Many and interacting components in com-
plex interventions, may decrease the chances of a “per-
fect match”, and the choice of an analogue may shortcut
or settle important challenges without appropriate con-
sideration. For example, viewing obesity as a metabolic
disease may shortcut important psychological and social
aspects highly relevant for successful treatment. Hence,
there is a chance of “over-simplification” and reducing
complex issues to “simple solutions”. On the other hand,
it may be possible that two cases are similar regarding
moral inferences, even though characteristics of com-
plexity are different. Casuistry does not address potential
variation in use or alternative use of interventions.
Uncertain causality Casuistry may be well suited to
handle uncertainty in cases where the analogues do so
as well. However, Casuistry (in HTA) is not suitable to
handle or compensate for emerging uncertainties during
the implementation and use of a complex intervention.
This is because the complex intervention being assessed
may develop differently from the paradigm cases. Al-
though the process in Casuistry can address methodo-
logical choices in HTA as well as cherish transparency,
this may be masked by the chosen analogue. For
example, viewing peptic ulcers as a stress related acid
imbalance definitely guided treatment and outcome
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assessment. However, in the view of present knowledge
about helicobacter pylori it is clear that the dominant
analogue was limited and limiting. Hence, it can be chal-
lenging to fulfil the requested justification of choices in
Casuistry due to uncertain causal pathways.
Unpredictable outcomes Some analogues (paradigm
cases) may include handling unpredictable outcomes,
but whether these are relevant for the given case will in-
evitably be subject to pure speculations. If one analogy
works for handling one outcome that could not be pre-
dicted, it is far from clear that it could do the same for
another. This means that Casuistry may address unpre-
dictable outcomes, but it may fail as well. Moreover,
Casuistry may give the impression that moral problems
are always solvable [22]. However, for radically new and
emerging technologies with dynamic challenges, such as
unpredictable outcomes, this may not be the case.
Ethical complexity Casuistry is excellent for finding so-
lutions to morally challenging problems. However, Casu-
istry does not provide solutions to genuine paradoxes
and aporias. It may find solutions by preferring one per-
spective or one principle over another, but not by resolv-
ing paradoxes. Framing “hearing disability” in the
perspective of sign culture does not resolve the tension
between the language perspective and the function re-
duction. Nevertheless, pragmatic (and compromising)
solutions in one area may inform potential solutions in
other fields.
In summary, Casuistry is well suited for addressing
several aspects of complexity as shown in Table 2. How-
ever, it may be less suitable for addressing uncertainty,
unpredictable outcomes, and ethical complexity. Using it
in an interactive way, however, could overcome some of
these shortcomings [19].
Wide Reflective Equilibrium (WRE)
Wide Reflective Equilibrium (WRE) is a coherentist
model of moral argumentation [23]. Coherentist, here, is
used in contrast to foundational approaches, which as-
sume that there are certain undisputable basic principles
from which moral judgments can be derived. Given
the—allegedly—undisputable nature of these basic prin-
ciples, the validity of moral judgments hinges on the val-
idity of the deductive argument. In a coherentist
approach, no such assumption is made. Instead, the val-
idity of a moral judgment depends on the coherence (or
mutual support) among general moral principle, moral
judgment, and background theory. The method has be-
come more widely known since it was used and advo-
cated by John Rawls in his Theory of Justice (1971) [24].
In this work, Rawls tries to argue that his concept of
justice as fairness is superior to the utilitarian concept of
justice. To do so, he argues that justice as fairness co-
heres with our considered moral judgments, and is inde-
pendently supported by background theory concerning
human behaviour, such as risk-aversiveness and mutual
cooperation. The method has been further elaborated by
Norman Daniels [25, 26]. Examples of assessments of
healthcare technology where the method of WRE has
been used include telemedicine-supported home care
[27], genetic engineering [28], and home environments
for adults with significant disability [29].
Wide Reflective Equilibrium and the characteristics of
complexity
Variety of perspectives WRE is a specific type of formal
model of moral argumentation. It can be used by an in-
dividual person to develop and justify a judgment of the
moral acceptability of a specific (healthcare) practice or
technology. For instance, to develop an argument to
challenge or support prenatal testing for autism. What
would be characteristic of the argument is that it claims
coherence (and hence mutual support) among the vari-
ous components (judgment, principle and background
theory), each of which may be scrutinized for its rele-
vance and validity separately. However, WRE may also
be employed in the context of a moral deliberation with
multiple participants. These could be selected to repre-
sent a variety of perspectives, e.g. patient, parent, care-
giver, healthcare professional, healthcare insurer, etc. In
such cases, WRE may be used to structure the develop-
ment of a collaborative argument, taking into account
multiple perspectives on a healthcare technology and
any associated differences in judgment of moral propri-
ety [30]. Some stakeholders might, for instance, consider
their acceptance of cochlear implants (CI) for deaf chil-
dren in equilibrium with the open future argument.
They might find independent support for their argument
from background theory of the association between
hearing, cognitive development and socio-emotional de-
velopment of children [31]. From the perspective of
WRE, this might be considered a provisional equilib-
rium, achieved by a number of stakeholders, which may
be challenged by others. The main advantage of WRE
would then be, then, to provide structure to the moral
argument, allowing participants to explore the coherence
among the various elements and the plausibility of the
background theory.
Indeterminate phenomena Not infrequently, different
interpretations of particular conditions or interventions
lie at the basis of ethical debates. In the case of the CI,
for instance, a considerable research effort has been di-
rected at assessing the impact of the technology on out-
comes such as hearing and the understanding and
production of spoken language [3]. However, from the
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perspective of Deaf Communities, a major concern was
the survival of Deaf Culture. From this, it may be in-
ferred that deafness was given a different interpretation.
By some, it was considered a medical condition (e.g.,
due to dysfunctional hair cells in the cochlea). By others,
deafness was rather considered a particular way of life
(Deafness as culture). WRE can help to identify such in-
determinacy, provided that multiple stakeholders have
an opportunity to contribute to the deliberation. A crit-
ical position toward CI (judgment) could then be related
to the idea that it would deprive deaf people from a
sense of self-esteem (principle), supported by a back-
ground theory on the relation between being part of a
culture and well-being. WRE might help participants to
use a deliberative process to reach agreement on what
interpretations should be taken into account.
Uncertain causality Perceiving ethical issues that are
associated with the use of a healthcare technology im-
plies causal attribution: ethical dilemmas are thought to
arise from the use of a healthcare technology. However,
things will usually be more complex than this. For in-
stance, whether the use of a healthcare technology re-
sults in ethical dilemma may, to a large extent, depend
on the social context. For instance, in Sweden, the use of
CI in deaf children seems to have been far less conten-
tious than in many other countries. This may be related
to the fact that in Sweden, an environment of equal op-
portunities and inclusive disability policies for its citizens
was maintained and that in education, a bilingualism
method of Swedish Sign Language and spoken Swedish
was used consistently in teaching deaf children [32].
WRE may help to identify such instances of more com-
plex, multifactorial causality, especially because it con-
sistently includes background theory in moral
arguments. A background theory supporting a critical
view of CI would lay out the consequences of CI for
Deaf Culture. A more refined background theory would
point out that CI is not sufficient cause for a demise of
Deaf Culture, and that particular aspects of the social
context may be equally important in this respect.
Unpredictable outcomes It is impossible to predict
how exactly a particular technology will be used over
time. For instance, the history of the CI goes back to the
1950s, when an electrode was inserted in the cochlea of
a deaf person for the first time [33]. At the time, it was
impossible to tell whether it would evolve into a clinic-
ally viable technology. After numerous technical im-
provements, the technology was initially used in people
who had lost hearing later in life. It was only when the
technology was used in deaf children, that a fierce de-
bate on its ethical acceptability started. Being a formal
method of moral argumentation, of course, WRE does
not have anything to offer in terms of a better under-
standing of technological change. However, this example
does show that judgements of the moral acceptability of
healthcare technologies should always be considered as
provisional and subject to change, notably when the use
of these technologies change over time. From the per-
spective of WRE, this may be interpreted as an instance
of a disruption of an existing equilibrium, calling for a
renewed debate.
Ethical complexity Probably one of the key causes of
ethical complexity is the commitment to a variety of
moral values within a community that seem to be in dir-
ect opposition and incompatible in concrete cases. Dif-
ferent schools of ethical thought vary in the way they
propose to resolve such dilemmas. The case of the CI
for deaf children was complex, not least because there
seemed to be a conflict between values such as ‘open fu-
ture’ and cultural diversity. WRE proposes to resolve
such value conflicts by trying to discover whether there
is differential support for such ‘narrow equilibria’ (be-
tween moral judgments and moral principles) from rele-
vant background theories. Clearly, this approach differs
substantially from other approaches such as weighing
and specification.
In summary, WRE allows an evaluator to take into ac-
count the complexity of an intervention and its sequelae,
since it explicitly addresses how judgments, principles
and background theory cohere with each other. How-
ever, to this end, it should be used as a method of moral
argumentation in the context of public deliberation,
allowing stakeholders to provide arguments from differ-
ent perspectives.
Interactive, participatory HTA approaches (iHTA)
Interactive Health Technology Assessment (iHTA) is a
specific approach to HTA, involving stakeholders
throughout the entire assessment process [34], i.e.
people who may experience the consequences of the as-
sessment are involved in defining the research ques-
tion(s) to be addressed (scoping), in designing the
assessment and in the collection and interpretation of
the data. The term ‘interactive’ refers to an interaction
among the various stakeholders: the explicit objective of
the HTA is that stakeholders learn from each other [34].
As such, iHTA is a specific type of frame-reflective ana-
lysis [35]: it aims to reconstruct and critically appraise
the frames that stakeholders use to interpret the problem
and to judge solutions. Typically, such reconstruction of
interpretative frames is achieved through semi-structured
interviews with stakeholders [36]. Philosophically, iHTA is
an approach to HTA which accepts fallibilism without
embracing scepticism, and which puts primacy on prac-
tice. As such, iHTA can be considered to be firmly rooted
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in pragmatism [37]. iHTA has been used to evaluate a
wide range of technologies, both within [30, 38] and out-
side the healthcare domain [39].
Interactive, participatory HTA approaches (iHTA) and the
characteristics of complexity
Variety of perspectives iHTA is pre-eminently suited to
take into account a variety of perspectives on a specific
problem and their associated (technological) solutions. It
acknowledges that ‘Assessment processes are embedded in
different sorts of institutional settings, within which scien-
tists, decision-makers, and advocates communicate to de-
fine relevant questions for analysis, mobilize certain kinds
of experts and expertise, and interpret findings in particu-
lar ways’ [40]. One of its key strengths may be that it helps
to reveal that problems may be defined quite differently
by various stakeholders; that stakeholders consider a dif-
ferent approach to resolve the problem, and that they em-
ploy different standards for evaluation. To increase a
sense of ownership and to increase the prospects for
implementing strategies for resolution, it is imperative that
such differences are identified early on in the assessment
process. Collaboratively, participants should decide on
relevant issues to address and feasible approaches of
inquiry. In the case of the cochlear implant (CI) for deaf
children, stakeholders radically differed in terms of the is-
sues of concern. Whereas healthcare providers tended to
emphasize research on the production and understanding
of speech, parents of deaf children also desired to know
whether CI might improve the reading skills of their child.
Representatives of Deaf Organizations wanted to know
how a CI might affect the self-esteem of the recipient at
the time they would become adolescent. One of the key
challenges in iHTA may be to organize the assessment
process in such a way, that the concerns of the various
perspectives are taken seriously and expressed in the ac-
tual inquiry. iHTA may be an effective means to achieve
this goal.
Indeterminate phenomena One of the key pitfalls in
HTA may be to take a (health) problem, its associated
solution and the evaluative framework as given. How-
ever, problems do not exist independently of the inter-
pretive frames that are being employed in particular
social contexts, nor do their solutions. The nature of the
problems that are posed by deafness may differ, depend-
ing on whose perspective is taken, and so may their so-
lutions. One of the key threats to the integrity of HTA is
to uncritically adopt a dominant way of framing an issue.
iHTA can help to prevent this from happening. In iHTA,
a technology and its use are not considered as fixed, or
given. Indeed, one of the key objectives of the assess-
ment is to discover, collaboratively, what the optimal use
of a technology in a particular context might be. In this
sense, iHTA is formative, rather than summative [41].
However, one challenge is to have all stakeholders
equally involved in the continuous re-definition of core
concepts. For instance, in the case of the CI, this would
mean that the objective of the HTA is not to establish
the value of the technology. Rather, the objective is to
define under what conditions the CI might be a valuable
option for all stakeholders involved. This gives rise to an
entirely different line of inquiry.
Uncertain causality Stakeholders can, and often do, dis-
agree on the likelihood that particular consequences will
emerge, following the use of a technology. iHTA can
serve as a useful approach to uncover such divergent
views, and to critically appraise their empirical and the-
oretical foundations. The reason for this is that an im-
portant element in iHTA is the reconstruction of
interpretative frames that stakeholders bring to the
inquiry. These include judgments of solutions, problem
definition, background theory, and normative prefer-
ences. Differences in judgment of solutions (their effect-
iveness, appropriateness, efficiency, etc.) can often be
traced back to differences in background theory [42].
Once these have been made explicit, their validity can be
more readily assessed. In the case of the CI, for instance,
some parents of deaf children preferred to postpone a
decision on CI until their child was old enough to be in-
volved in the decision. Although understandable, it
should be pointed out to such parents that the outcome
is likely to subside with increasing age at implantation.
The outcome of CI critically depends on a host of fac-
tors, including the age at implantation and the commu-
nication of the parents with the child. Addressing the
underlying mechanisms of child development may help
the various stakeholders in to understand these issues
better.
Unpredictable outcomes Adopting an Interactive ap-
proach to HTA (iHTA) will not allow for a more accur-
ate prediction of future outcomes. However, it will
usually lead to a wider range of relevant potential out-
comes. As indicated above, in the case of the CI for deaf
children, there was a strong focus on the impact of the
technology on hearing and the understanding and pro-
duction of spoken language. However, the (hearing) par-
ents of deaf children pointed out that for them, the
impact of the technology on the reading proficiency of
their child was hugely important [30]. Thus, an interactive
approach to HTA is likely to increase the range of out-
comes that are taken into account.
Ethical complexity One of the key advantages of an
interactive approach to HTA may be that it allows for a
better appreciation of the complexity of the ethical
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issues associated with the (use of ) a technology. The rea-
son for this is that the technology is viewed from a range
of perspectives, by stakeholders who bring different
values to the inquiry. For instance, in the case of the CI,
some stakeholders seemed to reason from the open-
future argument, while others put more emphasis on the
value of cultural diversity. Both represent defensible
moral positions, generally. The challenge is to acknow-
ledge such complexity and to devise acceptable solutions
in concrete cases. iHTA, of itself, does not provide the
tools to normatively assess the validity of ethical argu-
ments. For this, methods of moral argumentation such
as Wide Reflective Equilibrium or Casuistry may be used
in the context of an iHTA [30].
In summary, iHTA offers a way of systematically in-
volving multiple stakeholders, creating opportunities for
mutual learning and improved understanding. iHTA’s
emphasis is on procedural justice. Arguably, its main
added value will be in cases where quite divergent views
exist among stakeholders on the nature of the problem
to be solved and the most promising routes for its reso-
lution. This, in itself, may be considered to be an indica-
tion of complexity. In principle, the method is never
ending.
The HTA Core Model 3.0®
The HTA Core Model 3.0® has been developed in the
course of the European network for Health Technology
Assessment Joint Action 2 (EUnetHTA JA2) [43]. It con-
sists of nine domains, among which is the domain “eth-
ical analysis”. The “ethical analysis” domain is divided
into six topics; three of them (Beneficence/Non-malefi-
cence; Autonomy; Justice and Equity) are directly related
to the Principlist approach to bioethics (see paragraph
on Principlism). The other three topics are respect for
persons, legislation, and ethical consequences of the
HTA. Each topic consists of two to four questions, adding
up to nineteen assessment “issues”. Authors of HTAs are
encouraged to start by gathering information on ethical is-
sues using systematic literature searches, professional
guidelines, and the stakeholder views. In a second phase,
it is suggested that users choose from different methods
that have been assembled by a working group of the Inter-
national Network of Agencies for Health Technology As-
sessment (INAHTA) [44]. The choice of the method
should depend on factors such as the type of technology,
the role and authority of the HTA organisation, the time
and resources available and the expertise with ethical ana-
lysis available within the organization. For a comprehen-
sive analysis, it is recommended that more than a single
method is applied, and experts in ethical analyses are in-
volved, in addition to other scientists and clinicians [43].
“The need, weight and complexity placed on the ethical
analysis can differ between technologies, and for the same
technology for a rapid and full assessment depending on
the purpose and context of its use” [43].
Beyond the ethical domain, the HTA Core Model® in-
troduces ethics as a wider principle and provides a list of
ethical issues that should characterize each HTA. These
comprise e.g., stakeholder involvement, “morally relevant
reasons for performing/not performing a HTA” on spe-
cific topics, or the description of the interests of the
manufacturer. It acknowledges that the HTA-process it-
self is characterized by value judgments and that these
value judgments should be made explicit. Examples for
the ethical analysis guided by the HTA Core Model® are
an HTA on Multi-Slice Computed Tomography (MSCT)
[45] an HTA on Drug Eluting Stents (DES) [46] and an
HTA on Abdominal Aorta Aneurism Screening (AAA-
screening) [47].
The ethical domain in the HTA Core Model 3.0® and the
characteristics of complexity
Variety of perspectives The HTA Core Model® assesses
the implementation of a health technology from the per-
spective of the prevailing societal values and it looks at
the norms and values that the technology itself con-
structs. It also assesses the ethical issues related to per-
forming the HTA. Assessment involves explicitly looking
at the interests of different stakeholders at various levels;
among them patients, relatives, and society. Assessment
involves developing a table to synthesize the evidence
consequences of implementing or withdrawing the inter-
vention for the patient, family/important others, health
care providers, society, and others. The variety of per-
spectives is also reflected in the iterative process of the
analysis, including the involvement of different experts.
However, the active involvement of stakeholders, pa-
tients and the public seems to be difficult because of
time and resource constrains [45, 46] as well as the level
of the analysis [47]: “The general approach on the EU
level has to be put into operation at the local level. This
could be done using an Interactive participatory ap-
proach to HTA”. The AAA-screening example identified
the potential for different perspectives at the local level
with regard to issues of professional autonomy. How-
ever, differences between professionals and other partici-
pants are neither part of the analysis, nor related to one
another.
Indeterminate phenomena Defining the technology as
well as the target group is not directly addressed in the
ethical domain of the HTA Core Model®. Both are part
of the “Description and technical characteristics of tech-
nology” domain. Moral challenges linked with the defin-
ition of the intervention would be part of the iterative
ethical reflection during the assessment of this domain.
The domain asks for a detailed description of the
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intervention’s components including a glossary and in-
formation about the “scientifically proven versus sus-
pected mechanisms of action”. This is used to ensure
transparency and clarity about the technology.
Uncertain causality The HTA Core Model® encourages
the user to undertake the ethical analysis throughout the
HTA-process rather than seeing it as a “one session”
task. Multiple components and difficulties in determin-
ing the intervention and target group lead to uncertain
causal tracks. The ethics domain contains this up to a
certain point, e.g. asking for intended and unintended
consequences of the implementation or use of the tech-
nology and suggesting the involvement of different
stakeholders and the public from the very beginning of
the HTA. Furthermore the HTA Core Model® addresses
the context and non-technology-specific values such as
autonomy, dignity or integrity as well as professional
values and traditional roles.
Unpredictable outcomes Through a set of suggested is-
sues, the approach encourages the user to think about a
wide spectrum of possible outcomes and to link these
(iteratively) with outcome measures identified in the
other domains of the HTA Core Model®. The downside
of such an approach is that users might apply it as a fi-
nite list of issues ignoring other issues that are not expli-
citly mentioned. In the HTA Core Model® the
assessment questions are chosen at the beginning of the
ethical analysis. In the example of the AAA-screening
six assessment questions were marked as not relevant.
Among them were questions related to challenges of pa-
tient autonomy, potential benefits and harms for other
stakeholders.
One of the issues under the topic “beneficence/non-
maleficence” addresses “hidden or unintended conse-
quences of the technology and its applications for different
stakeholders”, and the ethical dimension of identifying
outcome measures is stressed explicitly through the topic
“Ethical consequences of the HTA”. Examples are inciden-
tal diagnoses related with the MSCT [45] or “off-label”-
use in the example of DES [46]. In the ethical reflection of
the AAA-Screening [47] this question was classified as
“not relevant” explaining that “hidden or unintended con-
sequences can only be considered on the local level”.
Ethical complexity Contradictions between basic eth-
ical principles are not explicitly mentioned in the HTA
Core Model®. The approach acknowledges that ethical
analysis, although being a separate domain, is closely in-
terrelated with aspects such as safety, clinical effective-
ness or cost-effectiveness. Collaboration between ethical
experts and stakeholders (e.g. clinicians) is suggested,
which could contribute to identify ethical complexity as
well as transparency. Stakeholder involvement may re-
veal fundamental values at stake and possible contradic-
ting principles and values.
In summary, the HTA Core Model® offers a structured
and transparent method for the ethical assessment of
technologies. The HTA Core Model® essentially follows
a Principlist approach and the use of tables as a basic
structure for analysis might impede the application of
approaches reflecting the consistency of ethical argu-
ments and background theories “without prescribing
which facts, arguments or principles are prima facie rele-
vant” (e.g., Coherent Analysis). A strong focus on the as-
sessment tables could mean that important aspects of a
specific technology are overlooked. The HTA Core
Model® addresses many of the complexity aspects, al-
though not always in a systematic way. The way meth-
odological approaches are linked with the assessment
tables remains open. Depending on the methodological
approach chosen the complexity of a health technology
will be more or less taken into account.
The Socratic approach
The Socratic approach is axiological as it studies values.
The aim is to uncover and highlight the values, norms
and ethical challenges that are relevant for the health
intervention, the HTA process, as well as for the deci-
sion making process. The Socratic approach consists of
six steps and seven basic morally relevant questions,
which are further specified in thirty-three explanatory
and guiding questions [7]. For clarity, we have provided
the number of steps and questions in parentheses when
comparing the Socratic approach with the complexity
characteristics below. The exact phrasing of steps and
questions can be found in the revised version of the ap-
proach by Hofmann et al [7].
The Socratic approach has been applied in a range of
assessments, e.g. of Bariatric surgery [48], Autologous
stem cell transplantation [49] and Welfare technology
[50]. These interventions carry some of the complexity
characteristics and indicate that the approach is feasible
for the assessment of complex health interventions.
The Socratic approach and the characteristics of complexity
Variety of perspectives Identifying persons, groups, and
stakeholders is a separate preparatory step (2) in this ap-
proach. In addition, the stakeholders respective perspec-
tives, interest, values and intention is the focus of many
of the questions from the list, e.g. questions about the
interests of users (Q19), producers (Q21), persons par-
ticipating in the HTA (Q28), and autonomy of the pro-
fessionals (Q20). Revealing the purpose and background
for the HTA (step 1) may also provide information on
stakeholder interests. Additionally, a reflexive dialogue
with stakeholders is recommended.
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The question of normative implications of interac-
tions/relationship between agents is indirectly and partly
covered by the question of relationship between patients
and health care professionals, and within the latter
group (Q12). Similarly, the general issue of interactions
between numerous (human and non-human) compo-
nents are briefly addressed (in Q16), but this may not be
ethically relevant unless they influence other characteris-
tics of complexity (e.g. outcome uncertainty). Many
characteristics of interactions between the intervention
as a whole and people/society are covered, e.g. the ques-
tions about whether use of the technology will change
the patient role (Q3).
Issues of control and decision-making and related re-
sponsibilities (as part of the technology itself) are not dir-
ectly addressed in this approach, though it is touched upon
in the question about impact of the technology on profes-
sional’s autonomy (Q20). The obligations of people doing
the HTA are more detailed as indicated in Q23 – 31.
Indeterminate phenomena Various understandings and
interpretations of the interventions can be explored as
part of the initial identification of the purpose of the
health intervention and background for the HTA (step
1). Additionally, the undefined nature of the complex in-
tervention(s) may be further illuminated by the recom-
mended stakeholder involvement. It seems paradoxical
that the scoping process and selection of experts/stake-
holders to include (Q26) is ever more important when
the concept and understanding of the intervention is
wide and unclear. Indeed, at the same time, this vague-
ness may confine the fraction of experts that it is pos-
sible to include. For example, in the case of Welfare
technology, which covers a heterogeneous group of tech-
nologies [50], the number of possible different experts/
stakeholders may be too large to include all/a reasonable
fraction.
The approach contains questions about moral issues
related to the characteristics of the technology (Q14-17),
and about the health condition and the target popula-
tion(s) (Q1 – 4). These may reveal indeterminacy and
contradictions, e.g. regarding purpose of the intervention
or the status of the disease. Consequently questions
about justification of flexibility, tailoring, alternative and
unexpected use of the intervention can be addressed.
Uncertain causality The Socratic approach includes
several questions about morally relevant methodological
choices in the HTA. For example, it includes, questions
about choice of end points, cut-off values and outcome
measures (Q23), selection (criteria) of studies to include
in the HTA (Q24), the choices in the HTA process from
planning (scoping, expert group selection) to presenting
results (Q26), specific presumptions and methodological
choices in the economical part of the assessment (Q27),
and timing of the assessment (Q29). Such questions can
illuminate how appropriate the HTA is for taking into ac-
count the uncertainties in causal pathway between inter-
vention and outcome, and pave the way for
improvements. Using the approach in an integrative man-
ner will increase transparency of methodological choices
and their justification.
The symbolic value of the intervention is addressed
(Q15) and the impact of context on outcome of analyses
is recognized. However, the relevance of these factors
may not be directly linked to their possible impact on
causal pathway between intervention and outcome. Sym-
bolic value and context may be ethically relevant for
other reasons, e.g. related to prestige and stigmatisation.
A systematic review of autologous stem cell transplant-
ation (ASCT) in advanced breast cancer, using the So-
cratic approach, illustrates how this intervention became
loaded with the symbolic value of “dissemination of
phase II trial results, coverage without evidence, falsified
data, high costs to the public and considerable, unneces-
sary harm to patients” [49]. In this case, the negative im-
pact on recruiting patients and the doctor-patient
relationship was reported.
Unpredictable outcomes Even if the variety of out-
comes (and for whom) is not addressed specifically,
many moral question about (potential) outcomes or con-
sequences are addressed: e.g. change of patient role
(Q3), effects on the distribution of health care (Q7), con-
sequences (benefits and harms) (Q8), moral obligations
(Q10), change of relationships (Q12), alteration of pro-
fessional autonomy (Q20).
The uncertainties (be it risk, uncertainty, ignorance, or
indeterminacy/ambiguity) in outcomes (type and size)
are not addressed as such, e.g. if some kind of uncer-
tainty itself may infer harm, challenge autonomy etc.
Ethical complexity The aim of the approach is to high-
light (underlying) values, viewpoints and arguments re-
garding an intervention that are important for decision-
making. This is achieved by comprehensiveness in the
normative issues addressed [49] (also including socio-
cultural and legal issues) and moral pluralism (incorpor-
ation of Deontology, Utilitarianism, Principlism, Casuis-
try, Virtue ethics) [7]. Altogether this should make a
solid basis for the additional step that may be required
in cases of complex interventions: to elucidate possible
contradictions and clarify their nature and solvability.
Whether the Socratic approach is developed for people
with or without philosophical qualification is not clear.
The method may be applied by HTA experts without
such qualifications, but not all questions are easy to ad-
dress [7]. For application on complex interventions, the
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approach may either be applied by trained philosophers/
ethicists, or be developed to include additional explana-
tions and guidance.
The thoroughness described above also makes the ap-
proach appropriate for revealing potential fundamental
values at stake, particularly if is applied in a reflexive dia-
logue with stakeholders as recommended. However, the
approach’s contribution to handling conflicting concerns
may be limited, or in fact be beyond its scope, as it is
modelled for assessments and not for appraisal. It is
clearly stated that the aim and scope of the approach is
to provide a descriptive assessment and to leave the ap-
praisal to those responsible for decision-making, but it is
recognized that more guidance on how to balance benefits
and harms in a systematic way would be valuable [7].
The Socratic approach aims at comprehensiveness in
documentation and reporting of the assessment process
(the six steps) [7], but this isn’t always apparent in publi-
cations applying the method. The most recent version
also includes additional recommendation e.g. regarding
information retrieval and selection, and quality checks of
extracted data. Transparency in all steps is highlighted,
not least about important stakeholders’ perspectives.
In summary, the Socratic approach meets the complexity
criteria fairly well. The most important points for improving
its applicability are: to address questions of decision making
and responsibility; to address the moral impact of indeter-
minacy and uncertain of outcome and finally, to offer
some guidance in how to balance conflicting concerns.
Conclusion
This study shows how the applicability for addressing
ethical issues in HTA of complex health interventions
differs between ethical approaches. The approaches are
assessed according to a set of five characteristics of com-
plex interventions, which in sum reflect their overall
ability to address ethical analysis for these kinds of tech-
nologies. In general, processual approaches, such as
Interactive, participatory HTA (iHTA), seem to be able
to handle most aspects of complexity. The interactive
and flexible nature of this approach makes it suitable for
handling the unpredictability embedded in complex in-
terventions. The flexibility and openness for different
perspectives may also explain why Wide Reflective Equi-
librium seems better suited for complex health interven-
tions than more rigid general approaches, such as
Principlism and Casuistry. The two latter approaches
should be supplemented with additional perspectives
and/or applied in a more interactive way, when assessing
complex health interventions. The two other HTA spe-
cific approaches, The HTA Core Model® and the Socratic
approach, also seem fairly applicable for complex health
interventions, which should not be surprising as they in-
clude various ethical approaches and perspectives.
We believe that our work will be helpful when choos-
ing and applying appropriate approaches for ethical ana-
lyses in HTA. However, one should be aware of other
important factors that may influence the choice and ap-
plication of an ethical approach, such as local HTA
agencies resources, possible locally developed guidelines
and whether the aim of the HTA is assessment or ap-
praisal. We also want to emphasise that all ethical ap-
proaches have limitations, and challenges associated
with conflicting values, interests and consideration
should always be expected in ethical analyses. Our study
can be helpful in preparing for some ethical assessment
challenges embedded in complex interventions, and in-
creases the awareness of ethical aspects of complex
health interventions in general.
Endnotes
1Health interventions seem to be the most commonly
used term in the complexity literature, and intervention
is a catch-all term, conflating quite separate initiatives
like a clinical treatment, a health care program, health
services delivery etc. [53]. Hence we understand and use
this term broadly as equivalent to the term health care
technology, which is also in accordance with the INAH-
TAs definition of health technology: “Any intervention
that may be used to promote health, to prevent, diag-
nose or treat disease or for rehabilitation or long-term
care. This includes the pharmaceuticals, devices, proce-
dures and organizational systems used in health care”
(our italics) [54].
2The term ‘complex’ refers to integrations between
connected things [55], which are causing unpredictability.
3The range of disciplines in (bio)medical ethics
includes for example (moral) philosophy, anthropology,
economics, epidemiology, health services research, his-
tory, law, literature, medicine, nursing, moral and social
psychology, social sciences, and theology.
4EUnetHTA was established first as a project, and later
as a network, with the aim of to support “collaboration
between European HTA organisations that brings added
value at the European, national and regional level
through: facilitating efficient use of resources available
for HTA, creating a sustainable system of HTA know-
ledge sharing, and promoting good practice in HTA
methods and processes” (http://www.eunethta.eu/)
5One reason for excluding ethical approaches rarely or
never used in HTA was the limited information available
for the analysis. Furthermore, the focus is on ethical ap-
proaches, which means that approaches for obtaining
and synthesising ethical data are not included.
6The complexity characteristics described in Table 1 are
not mutually exclusive. Overlapping between the charac-
teristics could be expected due to the nature of complexity.
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7Lysdahl KB, Hofmann B. Complex interventions:
Characteristics relevant for ethical analysis in health
technology assessment. Submitted manuscript.
8It would be valuable to apply a wide range of ethical
approaches for one and the same complex intervention
and compare the outcomes, but this would be highly
context dependent. To apply all ethical approaches for
the same complex interventions, in the same context,
would amend this, but it would be highly resource
demanding.
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